HCP(HCP)
HCP
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $888M | $1.27B |
| Low | $847M | $1.27B |
| High | $929M | $1.27B |
| EBITDA Avg | $-496M | $-712M |
| Low | $-519M | $-712M |
| High | $-473M | $-712M |
| EBIT Avg | $-509M | $-730M |
| Low | $-533M | $-730M |
| High | $-486M | $-730M |
| Net Income Avg | $147M | $138M |
| Low | $147M | $138M |
| High | $147M | $138M |
| EPS Avg | $0.76 | $0.71 |
| Low | $0.76 | $0.71 |
| High | $0.76 | $0.71 |
| Analysts (Rev / EPS) | 5 / 1 | 1 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $219M | $225M | $234M |
| Low | $219M | $225M | $234M |
| High | $219M | $225M | $234M |
| EBITDA Avg | $-122M | $-126M | $-131M |
| Low | $-122M | $-126M | $-131M |
| High | $-122M | $-126M | $-131M |
| EBIT Avg | $-125M | $-129M | $-134M |
| Low | $-125M | $-129M | $-134M |
| High | $-125M | $-129M | $-134M |
| Net Income Avg | $41M | $45M | $49M |
| Low | $41M | $45M | $49M |
| High | $41M | $45M | $49M |
| EPS Avg | $0.20 | $0.22 | $0.24 |
| Low | $0.20 | $0.22 | $0.24 |
| High | $0.20 | $0.22 | $0.24 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 1 / 2 |